Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0402 (-99.75%)
At close: Mar 11, 2026
Entia Biosciences Market Cap
Entia Biosciences has a market cap or net worth of $3.41 thousand as of March 26, 2026. Its market cap has decreased by -98.48% in one year.
Market Cap
3.41K
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 3.41K, a decrease of -99.90%. That is a compound annual growth rate of -31.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 3.41K | -66.67% |
| Dec 31, 2025 | 10.22K | 50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Xeno Transplants | 4.04K |
| MetaStat | 3.53K |
| Affimed | 3.28K |
| Rebus Holdings | 3.21K |
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |